Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) FCF Margin (2016 - 2025)

Historic FCF Margin for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to 12697.22%.

  • Perspective Therapeutics' FCF Margin fell 39148900.0% to 12697.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 12765.67%, marking a year-over-year decrease of 138328500.0%. This contributed to the annual value of 5171.27% for FY2024, which is 25223800.0% down from last year.
  • Latest data reveals that Perspective Therapeutics reported FCF Margin of 12697.22% as of Q3 2025, which was down 39148900.0% from 12268.42% recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' FCF Margin ranged from a high of 1613.51% in Q1 2024 and a low of 13426.71% during Q4 2024
  • Over the past 5 years, Perspective Therapeutics' median FCF Margin value was 413.17% (recorded in 2023), while the average stood at 3607.24%.
  • Per our database at Business Quant, Perspective Therapeutics' FCF Margin soared by 20945600bps in 2024 and then plummeted by -138742600bps in 2025.
  • Perspective Therapeutics' FCF Margin (Quarter) stood at 98.26% in 2021, then tumbled by -210bps to 107.92% in 2022, then skyrocketed by 272bps to 185.58% in 2023, then tumbled by -7335bps to 13426.71% in 2024, then increased by 5bps to 12697.22% in 2025.
  • Its FCF Margin was 12697.22% in Q3 2025, compared to 12268.42% in Q2 2025 and 12260.75% in Q1 2025.